» Articles » PMID: 36819340

A Literature Review of Similarities Between and Among Patients With Autism Spectrum Disorder and Epilepsy

Overview
Journal Cureus
Date 2023 Feb 23
PMID 36819340
Authors
Affiliations
Soon will be listed here.
Abstract

Autism spectrum disorder (ASD) has been shown to be associated with various other conditions, and most commonly, ASD has been demonstrated to be linked to epilepsy. ASD and epilepsy have been observed to exhibit high rates of comorbidity, even when compared to the co-occurrence of other disorders with similar pathologies. At present, nearly one-half of the individuals diagnosed with ASD also have been diagnosed with comorbid epilepsy. Research suggests that both conditions likely share similarities in their underlying disease pathophysiology, possibly associated with disturbances in the central nervous system (CNS), and may be linked to an imbalance between excitation and inhibition in the brain. Meanwhile, it remains unclear whether one condition is the consequence of the other, as the pathologies of both disorders are commonly linked to many different underlying signal transduction mechanisms. In this review, we aim to investigate the co-occurrence of ASD and epilepsy, with the intent of gaining insights into the similarities in pathophysiology that both conditions present with. Elucidating the underlying disease pathophysiology as a result of both disorders could lead to a better understanding of the underlying mechanism of disease activity that drives co-occurrence, as well as provide insight into the underlying mechanisms of each condition individually.

Citing Articles

Effect of Osteopathic Manipulation in an Autism Spectrum Child With Speech Impairment and Attention Deficit: A Case Report.

Sharath H, Raghuveer R, Qureshi M, Warghat P, Desai S, Brahmane N Cureus. 2024; 16(3):e56809.

PMID: 38654805 PMC: 11036344. DOI: 10.7759/cureus.56809.


Vasopressin as Possible Treatment Option in Autism Spectrum Disorder.

Laszlo K, Voros D, Correia P, Fazekas C, Torok B, Plangar I Biomedicines. 2023; 11(10).

PMID: 37892977 PMC: 10603886. DOI: 10.3390/biomedicines11102603.

References
1.
Leuzzi V, Mastrangelo M, Battini R, Cioni G . Inborn errors of creatine metabolism and epilepsy. Epilepsia. 2012; 54(2):217-27. DOI: 10.1111/epi.12020. View

2.
Zahra A, Wang Y, Wang Q, Wu J . Shared Etiology in Autism Spectrum Disorder and Epilepsy with Functional Disability. Behav Neurol. 2022; 2022:5893519. PMC: 9068331. DOI: 10.1155/2022/5893519. View

3.
Badescu G, Filfan M, Sandu R, Surugiu R, Ciobanu O, Popa-Wagner A . Molecular mechanisms underlying neurodevelopmental disorders, ADHD and autism. Rom J Morphol Embryol. 2016; 57(2):361-6. View

4.
Jambaque I, Chiron C, Dumas C, Mumford J, Dulac O . Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res. 2000; 38(2-3):151-60. DOI: 10.1016/s0920-1211(99)00082-0. View

5.
Prager E, Bergstrom H, Wynn G, Braga M . The basolateral amygdala γ-aminobutyric acidergic system in health and disease. J Neurosci Res. 2015; 94(6):548-67. PMC: 4837071. DOI: 10.1002/jnr.23690. View